EGFR and breast carcinoma: Next, the dual inhibition of FAK and epidermal growth factor receptor (EGFR) cooperatively led to apoptosis of breast cancer cells via caspase-3 and caspase-8 activation, cleavage of PARP and caspase-3-mediated AKT degradation [61].